Homepage > Company > Media > Pharma News > 2019 > Toshiba blood test detects cancer in hours

Toshiba blood test detects cancer in hours

Toshiba has announced that it has developed a blood test that can detect several cancers with 99 percent accuracy in just hours.

The Japanese firm teamed up with Tokyo Medical University and the National Cancer Center to develop the technology.

Toshiba scientists say the test measures the concentration of microRNA molecules released by cancer cells. They say it can detect 13 types of cancer in early stages, including pancreatic, stomach, and breast cancers.

The researchers say the tests are run through a small device that can identify the disease within two hours. They believe it could reduce the cost of cancer screening.

Toshiba plans to conduct further testing with the aim of commercializing the technology within a few years.

25 November

https://www3.nhk.or.jp/

Read also

New therapy from UI Health

New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes

FDA Probes Potential

FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy

BeiGene’s

BeiGene’s Tevimbra approved by EC for first-line gastric and oesophageal cancer use

Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug

Applied Therapeutics' application for a treatment of a rare metabolic disease was rejected by the Food and Drug Administration. The FDA said the drug, govorestat for galactosemia, had "defici...